2006Chinese Journal of Hospital PharmacyRequires access

Study of antibiotic resistance in ESBLs-producing strains

Jun Yan

Open publisher page 0 citations

Abstract

OBJECTIVE To investigate the productive status and the antibiotic resistance of extendedspectrum beta lactamases(ESBLs) in Escherichia coli and Klebsiella pneumoniae so as to provide necessary grounds to the clinical practice.METHODS A total of 854 strains of E.coli and 300 strains of K.pneumoniae were collected from clinical specimens.ESBLs production was performed by the standard disk diffusion method;drug susceptibility was detected by Kirby-Bauer disk diffusion method.RESULTS ESBLs productive rate of E.coli(K.pneumoniae) increased significantly from 26.4%(21.9%) to 48.6%(47.7%) at our hospital,during the years from 1999 to 2005.No strains were found to be resistant to imipenem.The resistance rates of ESBLs-producing E.coli strains to amikacin and nitrofurantoin were 17.9% and 6.2%,respectively,and over 74.4% to other antibiotics at 2005.The resistances of ESBLs-producing strains to most antimicrobials were much higher than that of non ESBLs-producing strains.CONCLUSION Antibiotics should be used rationally in the treatment of infections caused by ESBLs-producing strains. Imipenem could be of the first choice to treat the infection caused by ESBLs-producing strains.

About this research paper

What this paper is about

OBJECTIVE To investigate the productive status and the antibiotic resistance of extendedspectrum beta lactamases(ESBLs) in Escherichia coli and Klebsiella pneumoniae so as to provide necessary grounds to the clinical practice.METHODS A total of 854 strains of E.coli and 300 strains of K.pneumoniae were collected from clinical specimens.ESBLs production was performed by the standard disk diffusion method;drug susceptibility was detected by Kirby-Bauer disk diffusion method.RESULTS ESBLs productive rate of E.coli(K.pneumoniae) increased significantly from 26.4%(21.9%) to 48.6%(47.7%) at our hospital,during the years from 1999 to 2005.No strains were found to be resistant to imipenem.The resistance rates of ESBLs-producing E.coli strains to amikacin and nitrofurantoin were 17.9% and 6.2%,respectively,and over 74.4% to other antibiotics at 2005.The resistances of ESBLs-producing strains to most antimicrobials were much higher than that of non ESBLs-producing strains.CONCLUSION Antibiotics should be used rationally in the treatment of infections caused by ESBLs-producing strains. Imipenem could be of the first choice to treat the infection caused by ESBLs-producing strains.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To investigate the productive status and the antibiotic resistance of extendedspectrum beta lactamases(ESBLs) in Escherichia coli and Klebsiella pneumoniae so as to provide necessary grounds to the clinical practice.METHODS A total of 854 strains of E.coli and 300 strains of K.pneumoniae were collected from clinical specimens.ESBLs production was performed by the standard disk diffusion method;drug susceptibility was detected by Kirby-Bauer disk diffusion method.RESULTS ESBLs productive rate of E.coli(K.pneumoniae) increased significantly from 26.4%(21.9%) to 48.6%(47.7%) at our hospital,during the years from 1999 to 2005.No strains were found to be resistant to imipenem.The resistance rates of ESBLs-producing E.coli strains to amikacin and nitrofurantoin were 17.9% and 6.2%,respectively,and over 74.4% to other antibiotics at 2005.The resistances of ESBLs-producing strains to most antimicrobials were much higher than that of non ESBLs-producing strains.CONCLUSION Antibiotics should be used rationally in the treatment of infections caused by ESBLs-producing strains. Imipenem could be of the first choice to treat the infection caused by ESBLs-producing strains.

Key concepts: Amikacin, Imipenem, Klebsiella pneumoniae, Microbiology, Antibiotics, Nitrofurantoin, Antibiotic resistance, Drug resistance

Related papers

Back to paper searchBrowse research topicsOriginal source
Study of antibiotic resistance in ESBLs-producing strains — Research Paper | ScholarLens